The New Infrastructure of Biotech Entrepreneurship

​The New Infrastructure of Biotech Entrepreneurship

​Building a biotech company no longer means building everything yourself.

​Today’s founders are navigating a growing ecosystem of shared labs, CROs, fractional teams, AI-enabled tools, accelerators, and strategic partners that are changing how early-stage biotech companies get built.

​This session explores the new infrastructure of biotech entrepreneurship and how founders can leverage external resources to move faster, stay capital-efficient, and focus internal teams on the science and capabilities that matter most.

​You’ll Learn

• ​What early-stage biotech companies should build in-house vs. outsource

• ​How shared infrastructure is changing the cost of starting a biotech company

• ​When to leverage CROs, fractional teams, and strategic partners

• ​How founders can scale without building unnecessary infrastructure too early

​Who Should Attend?

• ​Pre-seed through Series A+ biotech founders

• ​Scientists exploring commercialization

• ​Startup operators and technical leaders

• ​Investors and venture partners

• ​Biotech service providers and ecosystem partners

​Hosted by MelanInScience as part of the BioInnovation Series during SF Tech Week.